| __timestamp | Amneal Pharmaceuticals, Inc. | Blueprint Medicines Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 31844000 |
| Thursday, January 1, 2015 | 136870000 | 48588000 |
| Friday, January 1, 2016 | 204747000 | 81131000 |
| Sunday, January 1, 2017 | 191938000 | 144687000 |
| Monday, January 1, 2018 | 210451000 | 243621000 |
| Tuesday, January 1, 2019 | 202287000 | 331450000 |
| Wednesday, January 1, 2020 | 190585000 | 326860000 |
| Friday, January 1, 2021 | 209563000 | 601033000 |
| Saturday, January 1, 2022 | 200046000 | 477419000 |
| Sunday, January 1, 2023 | 167778000 | 427720000 |
| Monday, January 1, 2024 | 341433000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Blueprint Medicines Corporation and Amneal Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment.
Blueprint Medicines has shown a remarkable increase in R&D expenses, growing from a modest 3% of Amneal's spending in 2014 to surpassing it by 2021. This upward trajectory highlights Blueprint's aggressive pursuit of groundbreaking therapies, with a peak in 2021 where their R&D expenses were nearly three times that of Amneal's.
Amneal Pharmaceuticals, on the other hand, has maintained a more consistent R&D budget, with fluctuations around the $200 million mark. Despite a slight dip in 2023, their steady investment reflects a balanced approach to innovation and market stability.
Novo Nordisk A/S or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
AbbVie Inc. vs Blueprint Medicines Corporation: Strategic Focus on R&D Spending
Merck & Co., Inc. or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Viatris Inc. vs Amneal Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Insmed Incorporated and Amneal Pharmaceuticals, Inc.
Research and Development Investment: Blueprint Medicines Corporation vs ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Blueprint Medicines Corporation and PTC Therapeutics, Inc.
Research and Development Expenses Breakdown: Blueprint Medicines Corporation vs Veracyte, Inc.
Analyzing R&D Budgets: Pharming Group N.V. vs Amneal Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and ImmunityBio, Inc.
Analyzing R&D Budgets: Amneal Pharmaceuticals, Inc. vs Veracyte, Inc.
R&D Insights: How Amneal Pharmaceuticals, Inc. and Travere Therapeutics, Inc. Allocate Funds